In D’Arcy v Myriad Genetics Inc [2014] FCAFC 115, five judges in the Full Federal Court of Australia have unanimously upheld a Federal Court decision that isolated nucleic acid such as isolated DNA and RNA is patentable subject matter in Australia. From our initial review, the Full Federal Court decision sets out not only the …
>> Read more
On 4 March 2013, a Notice of Appeal was filed by cancer survivor Yvonne D’Arcy against the decision of Cancer Voices Australia v Myriad Genetics Inc [2013] FCA 65 (“Cancer Voices”), which held that isolated nucleic acid such as isolated DNA and RNA is patentable subject matter in Australia. The Notice of appeal set out a number of …
>> Read more
An Australian Intellectual Property Litigation Round-Up from the Commonwealth Courts portal for the week ending 29 August 2014.
An Australian Intellectual Property Litigation Round-Up from the Commonwealth Courts portal for the week ending 22 August 2014.
An Australian Intellectual Property Litigation Round-Up from the Commonwealth Courts portal for the week ending 15 August 2014.
On 13 September 2014, changes to New Zealand Patent law come into effect which mean that renewal fees will be payable every year from the 4th anniversary. This is a significant change from the current law which only requires renewal in the 4th, 7th, 10th and 13th years. Because the current law permits patentees to …
>> Read more
An Australian Intellectual Property Litigation Round-Up from the Commonwealth Courts portal for the week ending 8 August 2014.
An Australian Intellectual Property Litigation Round-Up from the Commonwealth Courts portal for the week ending 1 August 2014.
An Australian Intellectual Property Litigation Round-Up from the Commonwealth Courts portal for the week ending 25 July 2014.
An Australian Intellectual Property Litigation Round-Up from the Commonwealth Courts portal for the week ending 18 July 2014.
